Conference - Boston, MA, United States
Rapidly evolving technologies are transforming the way reproductive genetic diagnostics and screening are performed, but the differences, limitations, and benefits of these new technologies remain unclear to some. Cambridge Healthtech Institute’s Inaugural Reproductive Genetic Diagnostics conference aims to examine the latest technologies, including next-generation sequencing (NGS) and quantitative PCR, and their benefits and applications in carrier screening, preimplantation diagnostics, and product of conception (POC) testing. As these technologies develop and become widespread, we must understand their capabilities, where each technology is best applied, and be sure that they have been analytically and clinically validated. Furthermore, as the technology outpaces practices, we must take a critical eye to the ethical implications of the applications of these technologies, including the regions of the genome that should be sequenced and the types and amount of sequence variation that is necessary for diagnosis. Join this event with your colleagues to meet with clinicians, researchers, developers, and key thought leaders and to examine these topics.
Organization: Cambridge Healthtech Institute
For more information, please visit: http://www.healthtech.com/
November 18-19, 2015
Omni Parker House
Boston, MA 02210, United States
Contact: Dave Mello (chi@healthtech.com)
Phone: 7819725400
